ALZAMEND NEURO, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ALZAMEND NEURO, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-04-30 was $1.00K.
- ALZAMEND NEURO, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-01-31 was $400.00.
- ALZAMEND NEURO, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-10-31 was $700.00.
- ALZAMEND NEURO, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-07-31 was $100.00.
- ALZAMEND NEURO, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $600.00.
- ALZAMEND NEURO, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $200.00, a 90.91% decline from fiscal 2022.
- ALZAMEND NEURO, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $2.20K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-04-30 | $600.00 10-K · filed 2026-07-22 | |
| 2023-04-30 | $200.00 10-K · filed 2024-07-30 | |
| 2022-04-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-27 | $2.20K 10-K · filed 2023-07-27 |
| 2022-01-31 | $400.00 10-Q · filed 2023-03-15 | |
| 2021-10-31 | $700.00 10-Q · filed 2022-12-12 | |
| 2021-07-31 | $100.00 10-Q · filed 2022-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |